中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2015年
24期
22-23
,共2页
谢宁%沈毅%唐扣明
謝寧%瀋毅%唐釦明
사저%침의%당구명
支气管哮喘%药学服务%临床药师
支氣管哮喘%藥學服務%臨床藥師
지기관효천%약학복무%림상약사
Bronchial asthma%Pharmaceutical services%Clinical pharmacists
目的:探讨临床药师对支气管哮喘患者开展药学服务的作用。方法将120例支气管哮喘患者随机分为干预组和对照组,每组60例,干预组实行药学服务干预措施,对照组给予常规的治疗和护理。出院后1个月和6个月对患者进行治疗评估,统计其用药依从性变化和哮喘控制程度。结果干预组干预后1个月和6个月用药依从性明显提高,分别为68.33%和61.67%,P<0.01差异有统计学意义。对照组干预后1个月有统计学差异(P<0.05),而6个月后无统计学差异(P>0.05)。两组在干预后1个月和6个月ACT得分均比干预前增高, P<0.01。两组在出院后6个月ACT得分有差异(P<0.01)。结论开展药学服务可提高支气管哮喘患者的长期用药依从性和哮喘控制率。
目的:探討臨床藥師對支氣管哮喘患者開展藥學服務的作用。方法將120例支氣管哮喘患者隨機分為榦預組和對照組,每組60例,榦預組實行藥學服務榦預措施,對照組給予常規的治療和護理。齣院後1箇月和6箇月對患者進行治療評估,統計其用藥依從性變化和哮喘控製程度。結果榦預組榦預後1箇月和6箇月用藥依從性明顯提高,分彆為68.33%和61.67%,P<0.01差異有統計學意義。對照組榦預後1箇月有統計學差異(P<0.05),而6箇月後無統計學差異(P>0.05)。兩組在榦預後1箇月和6箇月ACT得分均比榦預前增高, P<0.01。兩組在齣院後6箇月ACT得分有差異(P<0.01)。結論開展藥學服務可提高支氣管哮喘患者的長期用藥依從性和哮喘控製率。
목적:탐토림상약사대지기관효천환자개전약학복무적작용。방법장120례지기관효천환자수궤분위간예조화대조조,매조60례,간예조실행약학복무간예조시,대조조급여상규적치료화호리。출원후1개월화6개월대환자진행치료평고,통계기용약의종성변화화효천공제정도。결과간예조간예후1개월화6개월용약의종성명현제고,분별위68.33%화61.67%,P<0.01차이유통계학의의。대조조간예후1개월유통계학차이(P<0.05),이6개월후무통계학차이(P>0.05)。량조재간예후1개월화6개월ACT득분균비간예전증고, P<0.01。량조재출원후6개월ACT득분유차이(P<0.01)。결론개전약학복무가제고지기관효천환자적장기용약의종성화효천공제솔。
Objective?To investigate the clinical study conducted in patients with bronchial asthma pharmacist pharmacy services. Methods?120 cases of bronchial asthma were randomly divided into intervention group and control group. Intervention group was provided pharmacy services interventions and control group was received conventional treatment and care.1month and 6 months after treatment of patients assessed. Changes in medication adherence and asthma control were analyzed. Results?The medication compliance of intervention group was improved signiifcantly, one month 68.33%and six months 61.67%.The difference was statistically signiifcant (P<0.01).After 1 month there was signiifcant difference in the control group (P<0.05).But there was no signiifcant difference (P>0.05) 6 months after. In two groups of 1 months and 6 months after intervention ACT scores are higher than before (P<0.01).ACT scores are different of two groups in 6 months after intervention(P<0.01).Conclusion?Pharmaceutical care of patients with bronchial asthma can improve long-term medication adherence and asthma control.